Neonatal jaundice. Neonatal jaundice, unspecified
Conditions
Interventions
Intervention 1: Intervention group: In the intervention group, in addition to phototherapy, neonates receive from the first day of hospitalization at the rate of 4 mg per kg of body weight every 12 ho
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
2 Days to 10 Days
Inclusion criteria
Inclusion criteria: Term neonates who have the AAP criteria for the treatment of hyperbilirubinemia with phototherapy Healthy term neonates who have jaundice from the 2nd to the 10th day of birth and need phototherapy
Exclusion criteria
Exclusion criteria: Neonates with bilirubin level in range of blood exchange The neonate or mother has received phenobarbital Neonates with dehydration, sepsis, pneumonia, anemia, severe weight loss, hypoglycemia, renal failure, heart failure, possible hemolytic or inherited hemolytic disease, neonates with conjugated hyperbilirubinemia, neonates with G6PD, ABO or Rh incompatibility Neonates with a history of jaundice medication from two days before
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum bilirubin. Timepoint: 24,48 and 72 hours after starting phototherapy. Method of measurement: bilirubin kit. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSara Mohammadzadeh Rezaei
Mashhad University of Medical Sciences
Outcome results
None listed